Psychopharmacology: Sleep/Wake Disorders and Treatments

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/23

flashcard set

Earn XP

Description and Tags

Comprehensive vocabulary flashcards covering the neurobiology, sleep regulation processes, diagnostics, sleep-wake disorders, and pharmacological and non-pharmacological treatments from Week 9 Psychopharmacology lecture notes.

24 Terms

1
New cards

Process C (Circadian Rhythm)

The endogenous biological clock that governs physiological and behavioral rhythms across an approximate 24-hour cycle ("circa diem"), entrained by light and dark cues via the suprachiasmatic nucleus (SCN) of the hypothalamus.

2
New cards

Process S (Homeostatic Sleep Drive)

The physiological mechanism that tracks time spent awake and builds sleep pressure through the breakdown of ATP and accumulation of adenosine, which progressively dissipates during sleep.

3
New cards

Process U (Ultradian Cycle)

A biological rhythm that recurs multiple times within a 24-hour day with a period shorter than 24 hours (typically 90 to 120 minutes90\text{ to }120\text{ minutes}), governing the internal architecture of sleep stages and daytime focus fluctuations.

4
New cards

Basic Rest-Activity Cycle (BRAC)

A recurring daytime ultradian rhythm in which brain activity shifts between approximately 90 minutes90\text{ minutes} of high focus and alertness and 20 minutes20\text{ minutes} of natural fatigue or recovery need.

5
New cards

NREM Stage 3 Sleep

Deep, slow-wave sleep characterized by delta waves that lasts 20 to 40 minutes20\text{ to }40\text{ minutes} per cycle and comprises approximately 20%20\% of total sleep, crucial for physical repair, growth, immune function, and memory consolidation.

6
New cards

Disorders of Arousal (DoA)

A cluster of NREM parasomnias occurring during slow-wave sleep (N3) caused by a dissociation between sleep and wakefulness, wherein motor and limbic structures activate into wakefulness while associative cortices remain in deep slow-wave sleep.

7
New cards

Confusional Arousals

An arousal disorder typically occurring in the first third of the night upon partial awakening from deep NREM sleep, characterized by disorientation, slow or incoherent speech, a glassy stare, and subsequent morning amnesia.

8
New cards

Somnambulism (Sleepwalking)

A parasomnia involving complex motor behaviors performed during deep slow-wave sleep, ranging from walking to leaving the house, accompanied by a blank facial expression and complete lack of memory of the event.

9
New cards

Sleep Terrors (Pavor Nocturnus)

Intense arousal parasomnias characterized by sudden screaming, extreme agitation, and massive sympathetic autonomic activation (tachycardia, diaphoresis, dilated pupils) during slow-wave sleep, ending with rapid re-entry into sleep and amnesia.

10
New cards

Thalamic Gating

The regulatory process mediated by the reticular thalamic nucleus (TRN) and thalamocortical loops that controls external sensory transmission to the cerebral cortex across states of arousal.

11
New cards

Reticular Thalamic Nucleus (TRN)

A nucleus that hyperpolarizes thalamic relay neurons during sleep, generating delta waves and sleep spindles (11 to 15 Hz11\text{ to }15\text{ Hz}) to create a partial sensory gate that protects sleep continuity.

12
New cards

Polysomnography (PSG)

The gold-standard overnight laboratory diagnostic test that records electroencephalogram (EEG), electrooculogram (EOG), electrocardiogram (ECG), respiration, pulse oximetry, and electromyogram (EMG).

13
New cards

Multiple Sleep Latency Test (MSLT)

A daytime evaluation comprising 5 scheduled naps spaced across the day to measure objective sleepiness; a mean sleep latency of <8 minutes< 8\text{ minutes} paired with two or more Sleep-Onset REM Periods (SOREMs) indicates narcolepsy.

14
New cards

Actigraphy

An objective physiological monitoring method using a wrist-worn motion accelerometer over 1 to 2 weeks to record rest-activity patterns and estimate sleep parameters in a home environment.

15
New cards

Orexin (Hypocretin)

A wake-promoting neuropeptide produced exclusively in the lateral hypothalamus that stabilizes the Ascending Reticular Activating System (ARAS); its loss causes the fragmented state transitions of Narcolepsy Type 1.

16
New cards

Ventrolateral Preoptic Nucleus (VLPO)

A sleep-active hypothalamic region containing inhibitory neurons that release GABA and galanin to suppress wake-promoting nuclei in the brainstem and hypothalamus.

17
New cards

Flip-Flop Switch Model

A circuit model of sleep regulation where the sleep-promoting VLPO and wake-promoting ARAS mutually inhibit each other to produce rapid, distinct state transitions without intermediate stages.

18
New cards

Z-Drugs (Non-Benzodiazepines)

GABA-A receptor agonists (e.g., zolpidem, zopiclone, zaleplon) that selectively target the α1\alpha_1 subunit, delivering targeted sedative-hypnotic effects while preserving slow-wave and REM sleep architecture.

19
New cards

Dual Orexin Receptor Antagonists (DORAs)

A medication class (e.g., suvorexant, lemborexant, daridorexant) that facilitates sleep onset and maintenance by selectively blocking endogenous orexin-mediated wakefulness signals without globally suppressing cortical activity.

20
New cards

Eugeroics

Wakefulness-promoting medications (e.g., modafinil, armodafinil) that act as weak dopamine reuptake inhibitors to enhance daytime alertness with minimal peripheral autonomic stimulation.

21
New cards

Pitolisant

A wake-promoting agent that acts as a selective histamine H3H_3 receptor antagonist and inverse agonist, disinhibiting presynaptic autoreceptors to increase endogenous histamine release in the brain.

22
New cards

Oxybates (Sodium Oxybate / Calcium Oxybate)

Nighttime-administered therapeutic agents that consolidate slow-wave sleep, clinically indicated to reduce daytime sleepiness and cataplexy attacks in patients with narcolepsy.

23
New cards

Stimulus Control Therapy

A core CBT-I component aimed at breaking conditioned wakefulness and performance anxiety by instructing patients to get out of bed whenever they have been awake for 15 to 20 minutes15\text{ to }20\text{ minutes}.

24
New cards

Sleep Restriction Therapy

A behavioral technique within CBT-I that restricts total time spent in bed to equal the patient's actual baseline sleep duration, systematically increasing homeostatic sleep pressure.